Cost Plus Drugs LegitScript and Accreditation Status: What Patients Need to Know

What Is LegitScript, and Does Cost Plus Drugs Have It?

LegitScript is a third-party certification body that evaluates online pharmacies against standards set by the FDA, NABP, and applicable state boards. Pharmacies earn certification by passing compliance reviews covering prescription requirements, licensure, and drug sourcing. Cost Plus Drugs does not appear in LegitScript's public verified pharmacy database as of January 2025.

What LegitScript Certification Actually Means

LegitScript divides its pharmacy classifications into "Certified," "Rogue," and "Unapproved." A pharmacy that is not certified is not automatically rogue. Cost Plus Drugs falls into the unapproved category, meaning LegitScript has not completed a full compliance review of the company. The distinction matters: the FDA's BeSafeRx campaign lists LegitScript and NABP accreditation as two of its primary recommended signals for identifying safe online pharmacies. Absence of both marks is a consumer risk signal the FDA explicitly flags.

Why Cost Plus Drugs Has Not Pursued Certification

The company has not publicly disclosed why it has not applied for LegitScript certification. LegitScript itself charges application and annual maintenance fees, which some smaller or newer pharmacies cite as a barrier. Cost Plus Drugs is neither small nor poorly funded, so cost is an unlikely explanation. The more probable reason is that certification is voluntary, and the company's brand recognition, driven by significant media coverage, has reduced the commercial incentive to obtain it.

How to Check Certification Status Yourself

Patients can verify any online pharmacy's standing through three free tools. First, the LegitScript pharmacy verification search at legitscript.com/lookup. Second, the NABP .pharmacy accreditation list. Third, the FDA's list of Internet pharmacy warning letters. None of these resources currently list Cost Plus Drugs as verified or as having received an FDA warning letter.

NABP Accreditation: The Other Major Verification Standard

The National Association of Boards of Pharmacy runs the .pharmacy domain accreditation program, which requires pharmacies to demonstrate valid state licensure, prescription verification protocols, and sourcing exclusively from FDA-registered suppliers. Cost Plus Drugs does not hold this accreditation, and its domain ends in .com rather than the .pharmacy TLD.

NABP's Own Safety Guidance

The NABP publishes a "Not Recommended Sites" list of pharmacies it has investigated and found non-compliant. As of January 2025, Cost Plus Drugs does not appear on that list either. This means the company occupies a middle ground: not vetted and not condemned by the two most prominent pharmacy safety organizations. The FDA recommends that consumers confirm a pharmacy is state-licensed and requires valid prescriptions regardless of whether it holds third-party certification.

NABP's Minimum Requirements for Safe Online Pharmacies

According to the NABP's published consumer guidance, a safe online pharmacy should be licensed by the state board of pharmacy in the patient's state, require a valid prescription from a licensed practitioner, have a licensed pharmacist available to answer questions, and be located in the United States. Cost Plus Drugs satisfies the prescription-required and U.S.-location criteria. Whether it holds an active license in every state where it ships requires checking the relevant state board directly.

State Pharmacy Licensure and Texas Board Standing

Cost Plus Drugs operates its dispensing operations through its Texas facility. The Texas State Board of Pharmacy maintains a public license verification database where patients can confirm the pharmacy's active status. A Texas pharmacy license is a mandatory legal baseline, not a quality mark. It confirms only that the pharmacy met minimum state requirements at the time of licensure.

Interstate Shipping and Multi-State Licensing

Shipping prescription medications across state lines requires licensure in the originating state and, under many state laws, non-resident pharmacy permits in recipient states. The National Association of Boards of Pharmacy's Model Pharmacy Act sets out these requirements. Patients in states with strict non-resident pharmacy licensing rules should confirm that Cost Plus Drugs holds the permit required to ship to their address. The company's website states it ships to all 50 states, but it is the patient's responsibility to verify current licensure status with their state board.

Dispensing Partner: Truepill/Repackaging Services

Cost Plus Drugs originally contracted with Truepill for dispensing fulfillment. Truepill rebranded as Repackaging Services following a period of FDA scrutiny. In 2023, the FDA issued a Warning Letter to Truepill citing compounding violations related to a separate client's products. That warning letter did not specifically cite Cost Plus Drugs products, but it does document FDA compliance concerns about the dispensing infrastructure Cost Plus Drugs used during that period. Patients evaluating the pharmacy's safety record should weigh this context.

FDA Compliance and Drug Sourcing

Cost Plus Drugs purchases finished-dose medications from FDA-registered manufacturers and wholesalers operating under the Drug Supply Chain Security Act. The DSCSA, enacted in 2013, requires pharmacies to trace prescription drug products through the supply chain to verify authenticity and detect contamination or counterfeits. Compliance with DSCSA does not require third-party certification; it is a federal legal baseline all licensed U.S. Pharmacies must meet.

What FDA Registration of Manufacturers Actually Guarantees

FDA registration of a drug manufacturer confirms the facility has been listed with the agency and is subject to inspection under 21 CFR Part 207. It does not guarantee the specific lot of medication shipped to a patient has been inspected. The FDA inspects domestic drug manufacturers on a risk-based schedule, meaning some facilities go years between inspections. Patients taking medications sourced from generic manufacturers should check the FDA's Drug Shortages and Recalls database periodically for any recalls affecting products they use.

Cost Plus Drugs and Compounding

Some products sold on the Cost Plus Drugs platform are compounded medications. Compounded drugs are not FDA-approved; they are prepared by licensed compounding pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. The FDA's guidance on compounding makes clear that compounded drugs lack the safety and efficacy data required for FDA approval. Whether Cost Plus Drugs clearly distinguishes compounded from non-compounded products on its product pages is a transparency question patients should evaluate before purchasing.

BBB Complaints and Consumer Feedback

Cost Plus Drugs is not accredited by the Better Business Bureau. The BBB's business profile for Mark Cuban Cost Plus Drug Company shows a mix of resolved and unresolved consumer complaints. Common complaint themes in pharmacy-sector BBB filings typically involve shipping delays, order cancellation without notice, and billing disputes. The BBB complaint process is voluntary for businesses and reflects only complaints submitted through the BBB platform.

How to Interpret BBB Ratings for Online Pharmacies

The BBB rates businesses on a scale from A+ to F based on complaint volume, responsiveness, and time in business, among other factors. A pharmacy lacking BBB accreditation has simply chosen not to pay the accreditation fee, it is not automatically suspect. The FTC has published guidance cautioning consumers that BBB ratings alone are insufficient for evaluating online pharmacy safety. The more reliable signals remain state licensure, LegitScript status, and NABP accreditation, as the FDA's BeSafeRx page outlines.

Independent Consumer Review Sources

Beyond the BBB, patients can review complaint histories through ConsumerAffairs and state attorney general consumer protection portals. For pharmacy-specific concerns, the FDA MedWatch program accepts reports of adverse events tied to specific drug products, including those dispensed by online pharmacies. Filing a MedWatch report creates a public record that contributes to FDA's post-market surveillance.

The Pricing Model: Transparent but Unverified

Cost Plus Drugs publishes its pricing formula openly: manufacturer cost plus 15% markup plus a $3 dispensing fee plus $5 shipping. This level of pricing transparency is unusual in U.S. Pharmacy retail. However, "manufacturer cost" is not independently audited by any public body. The company's claims about pricing have not been verified by the CMS Office of the Actuary or any equivalent government body.

Comparison to GoodRx and Other Discount Programs

GoodRx operates as a pharmacy benefit manager intermediary, negotiating discounted prices through contracts with retail pharmacy chains. Cost Plus Drugs bypasses that model entirely, sourcing directly and adding a fixed markup. A 2023 analysis published in JAMA Internal Medicine found that Cost Plus Drugs prices were lower than GoodRx prices for a majority of the 40 drugs compared, with median savings of 79% versus retail cash prices. These savings are real for generic drugs but may not apply to brand-name medications, where manufacturer list prices constrain what any pharmacy can offer.

Insurance and Medicare Considerations

Cost Plus Drugs does not accept insurance. For patients with Medicare Part D or commercial prescription drug coverage, using Cost Plus Drugs means paying out of pocket and generally not having the purchase count toward annual deductibles or out-of-pocket maximums. The CMS Medicare Part D guidelines require that cost-sharing apply only to covered drugs dispensed by in-network pharmacies. Patients on fixed incomes or approaching their Part D catastrophic threshold should calculate total annual costs before switching to a cash-pay model.

Telehealth Integration and Prescribing Practices

Cost Plus Drugs does not employ prescribing physicians. It partners with third-party telehealth platforms that issue prescriptions for products sold on the site. This separation of prescribing and dispensing is standard pharmacy practice and not inherently problematic. The concern arises when the telehealth partner's prescribing standards are unclear. Patients should confirm that any telehealth service issuing prescriptions for Cost Plus Drugs products complies with their state's telemedicine prescribing laws and the DEA's Ryan Haight Online Pharmacy Consumer Protection Act for controlled substances.

Controlled Substances: A Specific Risk Area

Cost Plus Drugs does sell some controlled substances. Federal law under the Controlled Substances Act (21 USC 829) requires a valid prescription from a practitioner with a DEA registration for all Schedule II through V substances. The DEA's prescription requirements guidance specifies what constitutes a valid prescription. Patients receiving controlled substance prescriptions through a telehealth partner for fulfillment by Cost Plus Drugs should verify that the prescribing clinician holds an active DEA number, which can be checked through the DEA Diversion Control Division's registration database.

How Cost Plus Drugs Compares to Fully Accredited Online Pharmacies

Accredited pharmacies that hold both LegitScript certification and NABP .pharmacy accreditation have undergone documented third-party audits. The NABP's accreditation criteria require pharmacies to submit to random compliance checks, maintain pharmacist consultation availability, and demonstrate supply chain traceability. Cost Plus Drugs has not submitted to this level of external scrutiny.

The Risk Calculus for Patients

For patients buying widely available generic medications such as metformin 500 mg or lisinopril 10 mg, the risk of using a non-LegitScript-certified pharmacy is lower because these products are difficult to adulterate profitably and are manufactured by large FDA-regulated facilities. For patients purchasing specialty medications, hormones, or compounded preparations, the absence of third-party verification carries more weight. The FDA's guidance on counterfeit medicines notes that specialty and high-cost drugs are disproportionately targeted by counterfeiters, making supply chain verification more consequential.

What Fully Accredited Alternatives Offer

Pharmacies such as Blink Health's partner network, Costco Pharmacy (NABP accredited), and certain Health Mart independent pharmacies hold verified accreditations. These pharmacies may not always match Cost Plus Drugs' prices on generics, but they provide the audit trail and consumer protection infrastructure that third-party certification requires. Patients can search for NABP-accredited pharmacies near them using the NABP pharmacy locator.

What Regulators Say About Cash-Pay Online Pharmacies Generally

The FDA has not issued guidance specifically addressing the safety of cash-pay direct-to-consumer pharmacy models as a category. Its general online pharmacy guidance applies equally to all online pharmacies. The FTC has separately taken action against deceptive pricing claims by online pharmacies under Section 5 of the FTC Act. No FTC enforcement action against Cost Plus Drugs has been made public as of January 2025.

The National Association of Boards of Pharmacy's 2023 Internet Drug Outlet Report found that 96% of reviewed online pharmacy websites were out of compliance with applicable laws and standards. Cost Plus Drugs was not specifically cited in that report, but the statistic illustrates the baseline quality problem in the online pharmacy space that accreditation programs exist to address.